ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2012.00178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

Cancer Research
Cancer ResearchOncology
2010English

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

Oncotarget
Oncology
2015English

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4

SLAS Discovery
BiochemistryBiotechnologyAnalytical ChemistryMolecular Medicine
2019English

MYCN-regulated microRNAs Repress Estrogen Receptor- (ESR1) Expression and Neuronal Differentiation in Human Neuroblastoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

JMJD6 Is a Tumorigenic Factor and Therapeutic Target in Neuroblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma

Cancer Research
Cancer ResearchOncology
2006English

Multi-Drug Resistance Protein 4 (MRP4/ABCC4) and Cyclic Nucleotides Signaling Pathways

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy